Tag: tsx:hbp

May 1, 2019

Helix BioPharma Gives Update on L-DOS47 Phase II Study

Helix BioPharma announced the Trial Steering Committee reviewed safety data from the first dosing cohort of the Company’s LDOS003 study.
June 8, 2018

Helix BioPharma Closes Private Placement

Helix BioPharma (TSX:HBP) an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it...